March 26 (Reuters) - Drugmaker Mylan NV's merger with Pfizer Inc's off-patent branded drug unit, Upjohn, will now close within the second half of this 12 months, the businesses mentioned on Thursday, blaming the coronavirus pandemic for the delay.